Critical Risk Areas & Mitigation Plans
Duration: 50 min · Level: Foundational · Module: 10. G1 Development Roadmap · Focus: risk, mitigation, planning, G1
By the end of this lesson you will be able to explain and apply:
- Risk 1
- Risk 2
- Risk 3
- Risk 4
- Risk 5
Why this matters
Five technical risks have the highest potential to delay G1's 2030 launch or limit its market success.
Overview
Five technical risks have the highest potential to delay G1's 2030 launch or limit its market success. This lesson quantifies each risk and defines concrete mitigation strategies.
Key concepts
Risk 1 — Dexterous hand reliability: 22-DOF tendon systems have high maintenance requirements; mitigation: redundant tendon routing, rapid tendon replacement design, MTBF testing to 1000 hours by 2027
- Risk 2 — VLA policy failure modes: foundation models can fail silently on out-of-distribution inputs; mitigation: uncertainty quantification, human-in-the-loop override for high-stakes tasks, comprehensive failure mode testing
- Risk 3 — Battery life vs performance: 8-hour target requires careful power management; mitigation: duty-cycle profiling in target environments, regenerative actuators, task-based power modes
- Risk 4 — Regulatory approval for healthcare: EU MDR Class IIa device classification likely; mitigation: engage notified body in 2026, track IEC 62061 compliance from day 1, clinical trial plan by 2028
- Risk 5 — Sim-to-real gap for manipulation: household manipulation still fails in real-world conditions; mitigation: invest in real-world data collection infrastructure, teleop harness, data flywheel strategy
Check your understanding
Try to recall each answer before expanding it.
Q1. What do you know about Risk 1?
Dexterous hand reliability: 22-DOF tendon systems have high maintenance requirements; mitigation: redundant tendon routing, rapid tendon replacement design, MTBF testing to 1000 hours by 2027
Q2. What do you know about Risk 2?
VLA policy failure modes: foundation models can fail silently on out-of-distribution inputs; mitigation: uncertainty quantification, human-in-the-loop override for high-stakes tasks, comprehensive failure mode testing
Q3. What do you know about Risk 3?
Battery life vs performance: 8-hour target requires careful power management; mitigation: duty-cycle profiling in target environments, regenerative actuators, task-based power modes
Q4. What do you know about Risk 4?
Regulatory approval for healthcare: EU MDR Class IIa device classification likely; mitigation: engage notified body in 2026, track IEC 62061 compliance from day 1, clinical trial plan by 2028
Q5. What do you know about Risk 5?
Sim-to-real gap for manipulation: household manipulation still fails in real-world conditions; mitigation: invest in real-world data collection infrastructure, teleop harness, data flywheel strategy
← Previous: 10.1 G1 Architecture: Resolved Technology Decisions · Next: 10.3 2026–2030 Development Milestones →
Part of Module 10: G1 Development Roadmap.